Global Infectious Disease Therapeutics Market 2019-2023
- Published: Dec 2018
- Pages: 145
- SKU: IRTNTR30461
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The infectious disease therapeutics market size will grow by USD 16.99 billion during 2019-2023. This report offers an analysis of the market based on type (antiviral, antibacterial, antifungal, and others) and geography (the Americas, APAC, and EMEA). The infectious disease therapeutics market research report analyzes the market’s competitive landscape and offers information on several companies including AbbVie, F. Hoffmann-La Roche, Gilead, Merck, and Sanofi.
Below are some of the key findings from the infectious disease therapeutics market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global infectious disease therapeutics industry overview
The prevalence of infectious diseases is increasing rapidly over the years, resulting in a rising need for initiatives to increase disease awareness. As awareness campaigns on spotting the symptoms of infectious diseases and methods of prevention play a crucial role in preventing the spread of such infections, many organizations are taking initiatives to increase community awareness of these diseases. For instance, in June, Pfizer, collaborated with the UAE government to raise the awareness of infectious diseases. Therefore, the growing awareness of infectious diseases will propel the infectious disease therapeutics market growth during the forecast period.
The development of novel drugs will be one of the key infectious diseases therapeutics market trends that will positively impact growth throughout the forecast period. Increased investment towards R&D of novel drugs for the treatments of infectious diseases will lead to market growth. For instance, researchers at the Indian Institute of Science have discovered a new drug combination that promises better outcomes in treating tuberculosis. The drug called pranlukast can kill the tuberculosis bacterium as well as compromise its survival strategies within cells. Such developments will continue to fuel market growth over the next five years.
Top infectious disease therapeutics companies covered in this market research report
The infectious disease therapeutics market is moderately fragmented. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this infectious disease therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
- AbbVie
- F. Hoffmann-La Roche
- Gilead
- Merck
- Sanofi
Infectious disease therapeutics market segmentation based on geographic regions
- Americas
- APAC
- EMEA
With a comprehensive study of the growth opportunities for the companies, the Americas region will account for the highest infectious disease therapeutics market share throughout the forecast period. The dominant market share of the region is attributable to the rise in the prevalence of infectious diseases due to the sedentary lifestyle of people.
Infectious disease therapeutics market segmentation based on the type
- Antiviral
- Antibacterial
- Antifungal
The antiviral segment will account for the highest market share of the infectious disease therapeutics market. Additionally, the report also provides an accurate prediction of the contribution of the various segments to the growth of the infectious disease therapeutics market size.
Key highlights of the global infectious disease therapeutics market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the infectious disease therapeutics market during the next five years
- Precise estimation of the global infectious disease therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the infectious disease therapeutics industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of infectious disease therapeutics companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
- Pipeline analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Antiviral - Market size and forecast 2018-2023
- Antibacterial - Market size and forecast 2018-2023
- Antifungal - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Market trends
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie
- F. Hoffmann-La Roche
- Gilead
- Merck
- Sanofi
PART 14: APPENDIX
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
